# US 2022/0031244 A1 · Continuous analyte monitoring system with microneedle array

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0031244 A1
- Document ID: US20220031244A1
- Status: Published application
- Kind: A1
- Application number: 17/389,156
- Filed: 2021-07-29
- Published: 2022-02-03
- Earliest claimed: 2020-07-29
- Applicants: Biolinq Inc.
- Inventors: Joshua Ray WINDMILLER; Jared Rylan TANGNEY; Richard Chien YANG
- Web page: https://patentgrep.com/patent/US20220031244A1

## CPC

- A61B 5/685: {Microneedles}
- A61B 5/0022: {Monitoring a patient using a global network, e.g. telephone networks, internet}
- A61B 5/14514: {using means for aiding extraction of interstitial fluid, e.g. microneedles or suction}
- A61B 5/14532: {for measuring glucose, e.g. by tissue impedance measurement}
- A61B 5/14546: {for measuring analytes not otherwise provided for, e.g. ions, cytochromes}
- A61B 5/14865: {invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors}
- A61B 5/6833: {Adhesive patches}
- A61B 5/742: {using visual displays (displays for heart-related electrical signals, e.g. ECG, A61B5/339)}
- G01N 27/327: Biochemical electrodes {, e.g. electrical or mechanical details for in vitro measurements}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

Described herein are variations of an analyte monitoring system, including an analyte monitoring device. For example, an analyte monitoring device may include an implantable microneedle array for use in measuring one or more analytes (e.g., glucose), such as in a continuous manner. The microneedle array may include, for example, at least one microneedle including a tapered distal portion having an insulated distal apex, and an electrode on a surface of the tapered distal portion located proximal to the insulated distal apex. At least some of the microneedles may be electrically isolated such that one or more electrodes is individually addressable.

## Claims

### Claim at position 1

1-173. (canceled)

### Claim 174

A microneedle array for an analyte monitoring device, the microneedle array comprising:
a plurality of solid sensing microneedles, wherein each sensing microneedle comprises:
a tapered distal portion comprising a working electrode configured to sense an analyte; and
a body portion providing a conductive connection to the working electrode,
wherein the body portion of each sensing microneedle is insulated such that each working electrode is individually addressable and electrically isolated from every other working electrode in the microneedle array.

### Claim 175 (depends on 174)

The microneedle array of claim 174, wherein at least one sensing microneedle comprises a biorecognition layer arranged over the working electrode, wherein the biorecognition layer comprises a biorecognition element.

### Claim 176 (depends on 174)

The microneedle array of claim 174, wherein the biorecognition element comprises an enzyme.

### Claim 177 (depends on 176)

The microneedle array of claim 176, wherein the enzyme is glucose oxidase.

### Claim 178 (depends on 174)

The microneedle array of claim 174, wherein the microneedle array further comprises at least one microneedle comprising a counter electrode configured to source or sink current to sustain an electrochemical reaction on the working electrode of at least one sensing microneedle.

### Claim 179 (depends on 174)

The microneedle array of claim 174, wherein the plurality of microneedles comprises at least one microneedle comprising a reference electrode configured to provide a reference potential for the working electrode.

### Claim 180 (depends on 174)

The microneedle array of claim 174, wherein in at least one sensing microneedle, the tapered distal portion comprises an insulated distal apex and the working electrode is proximal to the insulated distal apex.

### Claim 181 (depends on 174)

The microneedle array of claim 174, wherein a distal end of the working electrode is offset from the distal apex.

### Claim 182 (depends on 181)

The microneedle array of claim 181, wherein the distal end of the working electrode is offset from the distal apex by an offset distance of at least about 10 μm, wherein the offset distance is measured along a longitudinal axis of the at least one sensing microneedle.

### Claim 183 (depends on 174)

The microneedle array of claim 174, wherein in at least one microneedle, a portion of the working electrode is recessed into the tapered distal portion.

### Claim 184 (depends on 174)

The microneedle array of claim 174, further comprising an electrical contact, wherein the at least one microneedle comprises a body portion providing a conductive pathway between the electrical contact and the electrode.

### Claim 185 (depends on 184)

The microneedle array of claim 184, wherein the body portion is formed from a conductive material.

### Claim 186 (depends on 184)

The microneedle array of claim 184, wherein the body portion comprises an embedded conductive pathway.

### Claim 187 (depends on 184)

The microneedle array of claim 184, wherein the body portion is insulated.

### Claim 188 (depends on 174)

An analyte monitoring device comprising the microneedle array of claim 174 and a wearable housing, wherein the microneedle array extends outwardly from the housing.

### Claim 189 (depends on 188)

The analyte monitoring device of claim 188, wherein the housing comprises one or more indicator lights configured to communicate status information.

### Claim 190 (depends on 188)

The analyte monitoring device of claim 188, wherein the analyte monitoring device is a skin-adhered patch.

### Claim 191

A method for monitoring a user, comprising:
accessing a dermal interstitial fluid of the user at a plurality of sensor locations with an integrated analyte monitoring device comprising a single microneedle array;
quantifying one or more analytes in the dermal interstitial fluid using a plurality of working electrodes in the microneedle array, wherein each working electrode is individually addressable and electrically isolated from every other working electrode in the analyte monitoring device.

### Claim 192 (depends on 191)

The method of claim 191, wherein quantifying one or more analytes comprises quantifying a plurality of analytes in the dermal interstitial fluid using the plurality of working electrodes.

### Claim 193 (depends on 192)

The method of claim 192, wherein the plurality of analytes comprises glucose.
